C12orf71
gene geneOn this page
Also known as LOC728858
Summary
C12orf71 (chromosome 12 open reading frame 71, HGNC:34452) is a protein-coding gene on chromosome 12p11.23, encoding Uncharacterized protein C12orf71 (A8MTZ7).
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 7 total
- MANE Select transcript:
NM_001080406
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34452 |
| Approved symbol | C12orf71 |
| Name | chromosome 12 open reading frame 71 |
| Location | 12p11.23 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LOC728858 |
| Ensembl gene | ENSG00000214700 |
| Ensembl biotype | protein_coding |
| Entrez | 728858 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000429849
RefSeq mRNA: 2 — MANE Select: NM_001080406
NM_001080406, NM_001384983
CCDS: CCDS44851
Canonical transcript exons
ENST00000429849 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001599870 | 27081968 | 27082578 |
| ENSE00002212830 | 27081057 | 27081467 |
Expression profiles
Bgee: expression breadth ubiquitous, 120 present calls, max score 86.38.
Top tissues by expression
127 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.38 | gold quality |
| left testis | UBERON:0004533 | 60.77 | gold quality |
| testis | UBERON:0000473 | 60.35 | gold quality |
| sural nerve | UBERON:0015488 | 60.02 | silver quality |
| right testis | UBERON:0004534 | 58.37 | gold quality |
| bone marrow | UBERON:0002371 | 57.21 | gold quality |
| corpus callosum | UBERON:0002336 | 56.45 | gold quality |
| granulocyte | CL:0000094 | 52.95 | gold quality |
| bone marrow cell | CL:0002092 | 51.97 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 51.51 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 50.49 | gold quality |
| cerebellar cortex | UBERON:0002129 | 50.32 | gold quality |
| ectocervix | UBERON:0012249 | 50.24 | gold quality |
| cerebellum | UBERON:0002037 | 50.03 | gold quality |
| skin of abdomen | UBERON:0001416 | 50.02 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 49.62 | silver quality |
| zone of skin | UBERON:0000014 | 49.43 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 49.20 | gold quality |
| body of pancreas | UBERON:0001150 | 48.96 | gold quality |
| left uterine tube | UBERON:0001303 | 48.90 | gold quality |
| esophagus mucosa | UBERON:0002469 | 48.82 | gold quality |
| skin of leg | UBERON:0001511 | 48.77 | gold quality |
| spleen | UBERON:0002106 | 48.56 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 48.54 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 48.12 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 48.11 | gold quality |
| primary visual cortex | UBERON:0002436 | 48.03 | gold quality |
| minor salivary gland | UBERON:0001830 | 47.97 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 47.66 | gold quality |
| apex of heart | UBERON:0002098 | 47.62 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.13 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
12 targeting C12orf71, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-6857-5P | 99.87 | 65.32 | 985 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-561-3P | 99.64 | 70.90 | 3647 |
| HSA-MIR-3915 | 99.45 | 68.49 | 1905 |
| HSA-MIR-500A-5P | 98.76 | 69.13 | 1241 |
| HSA-MIR-1246 | 98.54 | 66.21 | 959 |
| HSA-MIR-4450 | 98.26 | 68.35 | 725 |
| HSA-MIR-6881-5P | 98.16 | 67.38 | 665 |
| HSA-MIR-335-5P | 97.10 | 68.12 | 1022 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | 1700034J05Rik | ENSMUSG00000040163 |
| rattus_norvegicus | C4h12orf71 | ENSRNOG00000026864 |
Protein
Protein identifiers
Uncharacterized protein C12orf71 — A8MTZ7 (reviewed: A8MTZ7)
All UniProt accessions (1): A8MTZ7
RefSeq proteins (2): NP_001073875, NP_001371912 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027908 | DUF4640 | Family |
Pfam: PF15480
UniProt features (3 total): chain 1, region of interest 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A8MTZ7-F1 | 53.49 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 16 (showing top):
chr12p11, GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN, GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN, MIR561_3P, MIR3915, MIR335_5P, MIR1246, MIR4450, GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR, DESCARTES_FETAL_PANCREAS_ACINAR_CELLS, GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN, GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN, GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN, GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP, GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
82 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C12orf71 | YEATS4 | O95619 | 532 |
| C12orf71 | LYZL6 | O75951 | 531 |
| C12orf71 | SPRYD4 | Q8WW59 | 527 |
| C12orf71 | LYZL4 | Q96KX0 | 519 |
| C12orf71 | NUP107 | P57740 | 474 |
| C12orf71 | CPM | P14384 | 472 |
| C12orf71 | FRS2 | Q8WU20 | 466 |
| C12orf71 | TMEM64 | Q6YI46 | 445 |
| C12orf71 | ZNF215 | Q9UL58 | 419 |
| C12orf71 | ZBED2 | Q9BTP6 | 417 |
| C12orf71 | MIP | P30301 | 414 |
| C12orf71 | GLS2 | Q9UI32 | 383 |
| C12orf71 | KIF26B | Q2KJY2 | 366 |
| C12orf71 | SPACA5B | Q96QH8 | 363 |
| C12orf71 | BCAS3 | Q9H6U6 | 348 |
IntAct
0 interactions, top by confidence:
BioGRID (1): C12orf71 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0A1B0GU33, A0A1B0GUV7, A0A1L8FZ84, A4GZ95, A6ZT44, A8MTZ7, E1B9I5, G1XTZ6, P03562, P05909, P05910, P05911, P0C6G2, P0C6G4, P0C6G5, P0CK37, P0CK38, P12513, P14968, P21740, P26548, P27262, P27263, P27271, P32645, P33199, P36280, P38612, P43580, P87318, Q03937, Q09824, Q1A264, Q2V2P0, Q3KPS4, Q5T5A4, Q5T7R7, Q67621, Q6W0C5, Q88891
Diamond homologs: A8MTZ7, Q32LI3, Q66H53, Q80W69
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
7 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 4 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
93 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:27081467:TC:T | acceptor_loss | 0.9900 |
| 12:27081468:C:CA | acceptor_loss | 0.9900 |
| 12:27081472:C:CT | acceptor_gain | 0.9900 |
| 12:27081473:A:C | acceptor_gain | 0.9900 |
| 12:27081464:TCAT:T | acceptor_gain | 0.9800 |
| 12:27081465:CAT:C | acceptor_gain | 0.9800 |
| 12:27081465:CATC:C | acceptor_gain | 0.9800 |
| 12:27081468:C:CC | acceptor_gain | 0.9800 |
| 12:27081963:CTGA:C | donor_loss | 0.9800 |
| 12:27081964:TGACC:T | donor_loss | 0.9800 |
| 12:27081965:GACCT:G | donor_loss | 0.9800 |
| 12:27081966:A:AG | donor_loss | 0.9800 |
| 12:27081969:TGA:T | donor_gain | 0.9800 |
| 12:27081471:CCA:C | acceptor_gain | 0.9700 |
| 12:27081473:A:AC | acceptor_gain | 0.9700 |
| 12:27081472:C:T | acceptor_gain | 0.9600 |
| 12:27081473:A:T | acceptor_gain | 0.9500 |
| 12:27081952:ATT:A | donor_gain | 0.9500 |
| 12:27081463:ATCAT:A | acceptor_gain | 0.9300 |
| 12:27081954:T:TA | donor_gain | 0.9200 |
| 12:27081466:AT:A | acceptor_gain | 0.9100 |
| 12:27081479:A:C | acceptor_gain | 0.8900 |
| 12:27081900:A:C | donor_gain | 0.8900 |
| 12:27081814:ATC:A | donor_gain | 0.8600 |
| 12:27081968:C:G | donor_loss | 0.8600 |
| 12:27081479:A:AC | acceptor_gain | 0.8400 |
| 12:27081820:T:TA | donor_gain | 0.8200 |
| 12:27081966:A:AC | donor_gain | 0.8200 |
| 12:27081967:C:CC | donor_gain | 0.8200 |
| 12:27081869:AAG:A | donor_gain | 0.8000 |
AlphaMissense
1784 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:27082210:A:G | W92R | 0.909 |
| 12:27082210:A:T | W92R | 0.909 |
| 12:27082418:G:C | S22R | 0.901 |
| 12:27082418:G:T | S22R | 0.901 |
| 12:27082420:T:G | S22R | 0.901 |
| 12:27082400:G:C | F28L | 0.896 |
| 12:27082400:G:T | F28L | 0.896 |
| 12:27082402:A:G | F28L | 0.896 |
| 12:27082208:C:A | W92C | 0.873 |
| 12:27082208:C:G | W92C | 0.873 |
| 12:27081333:G:C | F217L | 0.851 |
| 12:27081333:G:T | F217L | 0.851 |
| 12:27081335:A:G | F217L | 0.851 |
| 12:27082235:A:C | F83L | 0.844 |
| 12:27082235:A:T | F83L | 0.844 |
| 12:27082237:A:G | F83L | 0.844 |
| 12:27082221:A:G | I88T | 0.812 |
| 12:27082083:A:G | L134P | 0.788 |
| 12:27082212:G:T | A91D | 0.783 |
| 12:27082061:A:C | F141L | 0.766 |
| 12:27082061:A:T | F141L | 0.766 |
| 12:27082063:A:G | F141L | 0.766 |
| 12:27082408:C:G | G26R | 0.748 |
| 12:27082301:C:A | W61C | 0.739 |
| 12:27082301:C:G | W61C | 0.739 |
| 12:27081325:A:G | L220P | 0.738 |
| 12:27082092:A:G | L131P | 0.730 |
| 12:27082071:A:G | F138S | 0.726 |
| 12:27082209:C:G | W92S | 0.717 |
| 12:27082207:C:G | D93H | 0.703 |
dbSNP variants (sampled 300 via entrez): RS1000129871 (12:27085369 T>C), RS1001286584 (12:27084413 A>G), RS1001359626 (12:27084183 T>C), RS1002287297 (12:27083336 C>A), RS1002359224 (12:27083117 T>A), RS1003360795 (12:27081732 G>A,C,T), RS1003986036 (12:27085765 G>A), RS1004316732 (12:27086069 C>T), RS1005871046 (12:27083292 C>T), RS1007194943 (12:27082442 G>A), RS1007497533 (12:27082732 C>T), RS1008192350 (12:27081063 G>A,T), RS1009841858 (12:27083383 A>G), RS1011845616 (12:27080886 G>A), RS1012183234 (12:27081038 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005759_6 | Dimensional psychopathology (Social) | 4.000000e-07 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009100 | social domain measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| fluorene-9-bisphenol | increases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Benzo(a)pyrene | decreases methylation, increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.